高鑫零售(06808.HK)中期扭虧為盈至2.06億元
格隆匯11月12日丨高鑫零售(06808.HK)公吿,截至2024年9月30日止6個月,來自銷售貨品的收入為人民幣331.86億元;公司擁有人應占溢利為人民幣2.06億元,較截至2023年9月30日止同期的虧損人民幣3.59億元扭轉增加人民幣5.65億元,增幅為157.4%。每股盈利0.02元。
截至2024年9月30日止6個月,同店銷售增長(按除去供應鏈業務貨品銷售計算)為0.3%。同店銷售增長主要來自客單價的增長,低價策略及商品策略提升用户心智,驅動筆單件增加,用户黏性提升。線下營收表現逐步回暖企穩,線上新渠道及自有APP成為推動同店銷售增長的主動力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.